Ioannis Lilis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ioannis Lilis has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Despina P. Kalogianni
Department of Chemistry, University of Patras, 26504 Patras, Greece
1 shared publication - Fotini Paliogianni
Department of Microbiology, University General Hospital of Patras, Rio, 26504 Patras, Greece
1 shared publication - Panagiotis Maglaras
Department of Chemistry, University of Patras, 26504 Rio, Patras, Greece
1 shared publication - Vasiliki Bravou
Department of Anatomy-Histology-Embryology, Medical School, University of Patras, Patras, Greece
1 shared publication
Latest Publications
- Open Access
- 26 October 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (11) , 926
A Molecular Lateral Flow Assay for SARS-CoV-2 Quantitative Detection
Since the onset of the SARS-CoV-2 pandemic, several COVID-19 detection methods, both commercially available and in the lab, have been developed using different biomolecules as analytes and different detection and sampling methods with high analytical performance. Developing novel COVID-19 detection assays is an exciting research field, as rapid accurate diagnosis is a valuable tool to control the current pandemic, and also because the acquired knowledge can be deployed for facing future infectious outbreaks. We here developed a novel gold-nanoparticle-based nucleic acid lateral flow assay for the rapid, visual, and quantitative detection of SARS-CoV-2. Our method was based on the use of a DNA internal standard (competitor) for quantification and involved RT-PCR, the hybridization of biotinylated PCR products to specific oligonucleotide probes, and detection with a dual lateral flow assay using gold nanoparticles conjugated to an anti-biotin antibody as reporters. The developed test allowed for rapid detection by the naked eye and the simultaneous quantification of SARS-CoV-2 in nasopharyngeal swabs with high specificity, detectability, and repeatability. This novel molecular strip test for COVID-19 detection represents a simple, cost-effective, and accurate rapid test that is very promising to be used as a future diagnostic tool.
- 26 October 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (11) , 926
Open AccessA Molecular Lateral Flow Assay for SARS-CoV-2 Quantitative Detection
Since the onset of the SARS-CoV-2 pandemic, several COVID-19 detection methods, both commercially available and in the lab, have been developed using different biomolecules as analytes and different detection and sampling methods with high analytical performance. Developing novel COVID-19 detection assays is an exciting research field, as rapid accurate diagnosis is a valuable tool to control the current pandemic, and also because the acquired knowledge can be deployed for facing future infectious outbreaks. We here developed a novel gold-nanoparticle-based nucleic acid lateral flow assay for the rapid, visual, and quantitative detection of SARS-CoV-2. Our method was based on the use of a DNA internal standard (competitor) for quantification and involved RT-PCR, the hybridization of biotinylated PCR products to specific oligonucleotide probes, and detection with a dual lateral flow assay using gold nanoparticles conjugated to an anti-biotin antibody as reporters. The developed test allowed for rapid detection by the naked eye and the simultaneous quantification of SARS-CoV-2 in nasopharyngeal swabs with high specificity, detectability, and repeatability. This novel molecular strip test for COVID-19 detection represents a simple, cost-effective, and accurate rapid test that is very promising to be used as a future diagnostic tool.